More on RYTM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $106.13 |
|
|||
| Open | $106.13 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $106.13 | ||||
| Day Low | $106.13 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 876 | ||||
- Deutsche Bank Starts Rhythm Pharmaceuticals (RYTM) at Hold
- Rhythm gets Japan approval for obesity drug Imcivree
- Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan
- Form 4 RHYTHM PHARMACEUTICALS, For: Aug 17 Filed by: Joshi Manher
- Form 3 RHYTHM PHARMACEUTICALS, For: Aug 17 Filed by: Joshi Manher
- Form 4 RHYTHM PHARMACEUTICALS, For: Aug 13 Filed by: Shulman Joseph
- Form 4 RHYTHM PHARMACEUTICALS, For: Aug 13 Filed by: Garfield Alastair
- Rhythm Pharmaceuticals names Manher Joshi as chief medical officer
- Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer
- Form 4 RHYTHM PHARMACEUTICALS, For: Aug 13 Filed by: Lee Jennifer Kayden
Entities mentioned with RYTM
- FDA | View Related Stories »
- PDUFA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Needham & Company | View Related Stories »
- Show More...
